Natco Pharma Board to Consider Q2 Results and Second Interim Dividend
Natco Pharma Ltd 路 Intimation 路 13 Nov 2026, 5:30 am
Natco Pharma Board to Consider Q2 Results and Second Interim Dividend Natco Pharma Limited's Board of Directors is scheduled to meet on 13th Nov'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the board will evaluate the declaration of a second interim dividend for FY27. In compliance with insider trading regulations, the trading window for dealing in company securities remains closed for designated persons and insiders from 30th Oct'26 through 15th Nov'26, re-opening on 16th Nov'26.
Original exchange filing (PDF)
More announcements from Natco Pharma Ltd
- Intimation of Investor Meet 路 17 Nov 2026
- Audio link of Earnings Conference Call Q2FY27 路 14 Nov 2026
- Q2 FY27 Earnings Presentation 路 13 Nov 2026
- Un audited Financial Results for the quarter and half year ended 30th September, 2026 路 13 Nov 2026
- 19th November, 2026 is the Record Date for the payment of 2nd Interim Dividend for FY 2026-27 路 13 Nov 2026
- Natco Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026 and declaration of 2nd Interim Dividend for FY 2026-27 路 13 Nov 2026
- Outcome of Board Meeting 路 13 Nov 2026
- Intimation of schedule of Concall 路 13 Nov 2026
